YALA:NYSEYalla Group Limited Analysis
Data as of 2026-05-12 - not real-time
$6.94
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Yalla Group Limited trades at $6.94, roughly 23.9% below its DCF‑derived fair value of $10.90, indicating a sizeable valuation cushion. The stock’s price‑to‑earnings multiple of 8.36 is dramatically lower than the software‑application industry average of 38.97, underscoring its relative cheapness. Despite a 7.7% revenue contraction, the company delivers a robust 43.8% profit margin and a 31.7% operating margin, reflecting a high‑quality earnings profile. With $753 million in cash and virtually no debt (debt‑to‑equity of 0.18), YALA enjoys a strong balance sheet and a debt‑free capital structure. Return on equity stands at 19.8% and return on assets at 9.0%, highlighting efficient capital deployment. Analyst consensus targets of $8.5–$8.6 suggest upside of roughly 20–25% from current levels.
Technical indicators are mixed: the 20‑day SMA (6.82) sits just below the market price, while the 200‑day SMA (7.16) remains above, yielding a neutral trend. RSI at 58 and a bullish MACD histogram (+0.022) point to modest short‑term momentum, yet the price is approaching the near‑term resistance of $7.09. Volatility over the past 30 days is 23%, and beta near 1 (0.98) imply market‑aligned risk. The “Extreme Greed” sentiment on the Fear & Greed Index reflects heightened investor optimism that may be tempering the stock’s discount. Upcoming Q1 2026 earnings on May 18 will be a key catalyst to confirm whether the valuation gap can be realized.
Technical indicators are mixed: the 20‑day SMA (6.82) sits just below the market price, while the 200‑day SMA (7.16) remains above, yielding a neutral trend. RSI at 58 and a bullish MACD histogram (+0.022) point to modest short‑term momentum, yet the price is approaching the near‑term resistance of $7.09. Volatility over the past 30 days is 23%, and beta near 1 (0.98) imply market‑aligned risk. The “Extreme Greed” sentiment on the Fear & Greed Index reflects heightened investor optimism that may be tempering the stock’s discount. Upcoming Q1 2026 earnings on May 18 will be a key catalyst to confirm whether the valuation gap can be realized.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near short‑term resistance at $7.09
- Neutral longer‑term trend with SMA alignment
- Upcoming earnings report on May 18
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- DCF upside of ~24% versus current price
- Low PE relative to industry peers
- Strong cash reserves and minimal debt
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- High profitability margins and ROE
- Growth potential in MENA social gaming market
- Undervalued valuation metrics with attractive upside
Key Metrics & Analysis
Financial Health
Revenue Growth-7.70%
Profit Margin43.82%
P/E Ratio8.4
ROE19.75%
ROA9.00%
Debt/Equity0.18
P/B Ratio1.3
Op. Cash Flow$137.5M
Free Cash Flow$67.6M
Industry P/E39.0
Technical Analysis
TrendNeutral
RSI58.3
Support$6.53
Resistance$7.09
MA 20$6.82
MA 50$6.63
MA 200$7.16
MACDBullish
VolumeStable
Fear & Greed Index88.61
Valuation
Fair Value$10.90
Target Price$8.60
Upside/Downside23.92%
GradeUndervalued
TypeValue
Risk Assessment
Beta0.98
Volatility23.24%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
ZKH
ZKH Group Limited
STOCKZJYL
JIN MEDICAL INTERNATIONAL LTD.
STOCKZJK
ZJK Industrial Co., Ltd.
STOCKZIP
ZipRecruiter, Inc.
STOCKZIONP
Zions Bancorporation N.A. - Depositary Shares each representing a 1/40th ownership interest in a share of Series A Floating-Rate Non-Cumulative Perpetual Prefer
STOCKZION
Zions Bancorporation N.A.
STOCKThis analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.